Cargando…

Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways

The present study aimed to evaluate the effects of paeoniflorin on insulin resistance and hepatic steatosis induced by fructose. Male Sprague-Dawley rats were fed 20% fructose drink for eight weeks. The insulin sensitivity, serum lipid profiles, and hepatic lipids contents were measured. The results...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yu-Cheng, Qiao, Jing-Yi, Wang, Bao-Ying, Bai, Ming, Shen, Ji-Duo, Cheng, Yong-Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116094/
https://www.ncbi.nlm.nih.gov/pubmed/30081580
http://dx.doi.org/10.3390/nu10081024
_version_ 1783351531105419264
author Li, Yu-Cheng
Qiao, Jing-Yi
Wang, Bao-Ying
Bai, Ming
Shen, Ji-Duo
Cheng, Yong-Xian
author_facet Li, Yu-Cheng
Qiao, Jing-Yi
Wang, Bao-Ying
Bai, Ming
Shen, Ji-Duo
Cheng, Yong-Xian
author_sort Li, Yu-Cheng
collection PubMed
description The present study aimed to evaluate the effects of paeoniflorin on insulin resistance and hepatic steatosis induced by fructose. Male Sprague-Dawley rats were fed 20% fructose drink for eight weeks. The insulin sensitivity, serum lipid profiles, and hepatic lipids contents were measured. The results showed that paeoniflorin significantly decreased serum insulin and glucagon levels, improved insulin sensitivity and serum lipids profiles, and alleviated hepatic steatosis in fructose-fed rats. Moreover, paeoniflorin enhanced the phosphorylation level of AMP-activated protein kinase (AMPK) and protein kinase B (PKB/AKT) and inhibited the phosphorylation of acetyl coenzyme A carboxylase (ACC)1 in liver. Paeoniflorin also increased the hepatic carnitine palmitoyltransferase (CPT)-1 mRNA and protein expression and decreased the mRNA expression of sterol regulatory element-binding protein (SREBP)1c, stearyl coenzyme A decarboxylase (SCD)-1 and fatty acid synthetase (FAS). Furthermore, we found that paeoniflorin significantly increased the heptatic protein expression of tumor suppressor serine/threonine kinase (LKB)1 but not Ca(2+)/CaM-dependent protein kinase kinase (CaMKK)β. These results suggest that the protective effects of paeoniflorin might be involved in the activation of LKB1/AMPK and insulin signaling, which resulted in the inhibition of lipogenesis, as well as the activation of β-oxidation and glycogenesis, thus ameliorated the insulin resistance and hepatic steatosis. The present study may provide evidence for the beneficial effects of paeoniflorin in the treatment of insulin resistance and non-alcoholic fatty liver.
format Online
Article
Text
id pubmed-6116094
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-61160942018-09-04 Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways Li, Yu-Cheng Qiao, Jing-Yi Wang, Bao-Ying Bai, Ming Shen, Ji-Duo Cheng, Yong-Xian Nutrients Article The present study aimed to evaluate the effects of paeoniflorin on insulin resistance and hepatic steatosis induced by fructose. Male Sprague-Dawley rats were fed 20% fructose drink for eight weeks. The insulin sensitivity, serum lipid profiles, and hepatic lipids contents were measured. The results showed that paeoniflorin significantly decreased serum insulin and glucagon levels, improved insulin sensitivity and serum lipids profiles, and alleviated hepatic steatosis in fructose-fed rats. Moreover, paeoniflorin enhanced the phosphorylation level of AMP-activated protein kinase (AMPK) and protein kinase B (PKB/AKT) and inhibited the phosphorylation of acetyl coenzyme A carboxylase (ACC)1 in liver. Paeoniflorin also increased the hepatic carnitine palmitoyltransferase (CPT)-1 mRNA and protein expression and decreased the mRNA expression of sterol regulatory element-binding protein (SREBP)1c, stearyl coenzyme A decarboxylase (SCD)-1 and fatty acid synthetase (FAS). Furthermore, we found that paeoniflorin significantly increased the heptatic protein expression of tumor suppressor serine/threonine kinase (LKB)1 but not Ca(2+)/CaM-dependent protein kinase kinase (CaMKK)β. These results suggest that the protective effects of paeoniflorin might be involved in the activation of LKB1/AMPK and insulin signaling, which resulted in the inhibition of lipogenesis, as well as the activation of β-oxidation and glycogenesis, thus ameliorated the insulin resistance and hepatic steatosis. The present study may provide evidence for the beneficial effects of paeoniflorin in the treatment of insulin resistance and non-alcoholic fatty liver. MDPI 2018-08-05 /pmc/articles/PMC6116094/ /pubmed/30081580 http://dx.doi.org/10.3390/nu10081024 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Li, Yu-Cheng
Qiao, Jing-Yi
Wang, Bao-Ying
Bai, Ming
Shen, Ji-Duo
Cheng, Yong-Xian
Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
title Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
title_full Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
title_fullStr Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
title_full_unstemmed Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
title_short Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways
title_sort paeoniflorin ameliorates fructose-induced insulin resistance and hepatic steatosis by activating lkb1/ampk and akt pathways
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116094/
https://www.ncbi.nlm.nih.gov/pubmed/30081580
http://dx.doi.org/10.3390/nu10081024
work_keys_str_mv AT liyucheng paeoniflorinamelioratesfructoseinducedinsulinresistanceandhepaticsteatosisbyactivatinglkb1ampkandaktpathways
AT qiaojingyi paeoniflorinamelioratesfructoseinducedinsulinresistanceandhepaticsteatosisbyactivatinglkb1ampkandaktpathways
AT wangbaoying paeoniflorinamelioratesfructoseinducedinsulinresistanceandhepaticsteatosisbyactivatinglkb1ampkandaktpathways
AT baiming paeoniflorinamelioratesfructoseinducedinsulinresistanceandhepaticsteatosisbyactivatinglkb1ampkandaktpathways
AT shenjiduo paeoniflorinamelioratesfructoseinducedinsulinresistanceandhepaticsteatosisbyactivatinglkb1ampkandaktpathways
AT chengyongxian paeoniflorinamelioratesfructoseinducedinsulinresistanceandhepaticsteatosisbyactivatinglkb1ampkandaktpathways